Sign up to save your podcasts
Or
Share GeoVax CEO to Present Mpox Vaccine Candidate Progress at CEO Presentation and Q&A Webinar Event
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
GeoVax CEO to Present Mpox Vaccine Candidate Progress at CEO Presentation and Q&A Webinar Event
GeoVax CEO, David Dodd, will be presenting at Tribe Public's CEO Presentation and Q&A Webinar Event on March 6, 2025, providing updates on GeoVax's Mpox vaccine candidate, GEO-MVA. The vaccine is progressing towards clinical evaluation in the second half of 2025, aiming to address the ongoing global public health emergency caused by Mpox.
View all episodes
GeoVax CEO, David Dodd, will be presenting at Tribe Public's CEO Presentation and Q&A Webinar Event on March 6, 2025, providing updates on GeoVax's Mpox vaccine candidate, GEO-MVA. The vaccine is progressing towards clinical evaluation in the second half of 2025, aiming to address the ongoing global public health emergency caused by Mpox.